ID   U2OS FKHRL1-EGFP
AC   CVCL_KA04
SY   FKHRL1_U2OS
DR   Wikidata; Q54973654
WW   Provider; Thermo Fisher; R04-009-02; https://tools.thermofisher.com/content/sfs/manuals/D03267~.pdf
CC   Population: Caucasian.
CC   Characteristics: Transfected with a fusion FOXO3-eGFP protein under the control of the CMV promoter (Thermo Fisher=R04-009-02).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3821; FOXO3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Discontinued: Thermo Fisher/BioImage; Catalog number R04-009-02.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//